24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Clinical trial NCT02182830 · COMPLETED
Trial details
- NCT number
- NCT02182830
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-25
- Primary completion
- 2017-05-18
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.